Biotalys NV

Brussels Stock Exchange BTLS.BR

Biotalys NV Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 6.10 M

Biotalys NV Net Cash Used Provided By Financing Activities is USD 6.10 M for the year ending December 31, 2023, a 559.32% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Biotalys NV Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -1.33 M, a -102.29% change year over year.
  • Biotalys NV Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 58.15 M, a 211.23% change year over year.
  • Biotalys NV Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 18.68 M, a -31.91% change year over year.
  • Biotalys NV Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 27.44 M.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
Brussels Stock Exchange: BTLS.BR

Biotalys NV

CEO Mr. Kevin R. Helash
IPO Date July 2, 2021
Location Belgium
Headquarters Buchtenstraat 11
Employees 75
Sector Consumers Staples
Industries
Description

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

StockViz Staff

February 8, 2025

Any question? Send us an email